Biden likely to sign a bill that would crack down on China's chokehold on the antibiotic supply
The Senate on Monday passed (68-28) a wide-ranging, Biden-backed and already House-passed bill that would bolster American manufacturing, and try to crack down on China’s control of certain vital supplies like pharmaceuticals.
China quickly reached the forefront of API and generic drug manufacturing worldwide over the last decade, thanks in part to low labor costs, as the FDA’s data show the number of registered facilities making APIs in China more than doubled between 2010 and 2019.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.